Načítá se...
Immunotherapy and next-generation sequencing guided therapy for precision oncology: What have we learnt and what does the future hold?
INTRODUCTION: The rapid development of clinical next generation sequencing (NGS) and the contemporaneous availability of molecular targeted therapies ignited and fueled the field of precision oncology. More recently there has been an explosion of immunotherapeutic agents, specifically the checkpoint...
Uloženo v:
| Vydáno v: | Expert Rev Precis Med Drug Dev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6934166/ https://ncbi.nlm.nih.gov/pubmed/31886407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23808993.2018.1480898 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|